{"id":4428289,"date":"2026-05-18T07:00:00","date_gmt":"2026-05-18T12:00:00","guid":{"rendered":"https:\/\/olartemoure.com\/?p=4428289"},"modified":"2026-05-14T21:21:40","modified_gmt":"2026-05-15T02:21:40","slug":"colombia-revises-drug-price-controls","status":"publish","type":"post","link":"https:\/\/olartemoure.com\/en\/colombia-revises-drug-price-controls\/","title":{"rendered":"Colombia Revises Drug Price Controls"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; theme_builder_area=&#8221;post_content&#8221; _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221;][et_pb_row _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; theme_builder_area=&#8221;post_content&#8221; width=&#8221;100%&#8221; hover_enabled=&#8221;0&#8243; sticky_enabled=&#8221;0&#8243;][et_pb_column _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; type=&#8221;4_4&#8243; theme_builder_area=&#8221;post_content&#8221;][et_pb_text _builder_version=&#8221;4.27.6&#8243; _module_preset=&#8221;default&#8221; theme_builder_area=&#8221;post_content&#8221; hover_enabled=&#8221;0&#8243; sticky_enabled=&#8221;0&#8243;]The National Commission for Medicines and Medical Devices Pricing published a second draft of Circular 20 in May 2026 (the first was in December 2025). This updated framework presents valuable opportunities for the pharmaceutical and healthcare sector.  <\/p>\n<p>The revised text sets the regulated monetary adjustment at a 7.4% reduction. This smartly corrects calculations by expanding the review to 24 months, up to December 2025.  <\/p>\n<p>Additionally, it defines two distinct rates: for international comparisons and for current price updates. The update broadens adjustments to 40 entries, a 74 percent increase impacting specialized therapies. The text integrates 34 new markets and 5 subcategories into the direct control regime. Crucially, it introduces practical units like kits for cystic fibrosis and separates formulas, such as tenofovir variations.  <\/p>\n<p>Furthermore, it explicitly names the 8 markets reviewed by request, including ibuprofen and also thalidomide. This update establishes pricing architecture designed to foster the sustainability of the health system. [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The update broadens adjustments to 40 entries, a 74 percent increase impacting specialized therapies.<\/p>\n","protected":false},"author":5,"featured_media":4428291,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[59],"tags":[],"class_list":["post-4428289","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-newsletter-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.6 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Colombia Revises Drug Price Controls - OlarteMoure | Intellectual Property<\/title>\n<meta name=\"description\" content=\"The update broadens adjustments to 40 entries, a 74 percent increase impacting specialized therapies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/olartemoure.com\/revision-control-precios-medicamentos\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Colombia Revises Drug Price Controls\" \/>\n<meta property=\"og:description\" content=\"The update broadens adjustments to 40 entries, a 74 percent increase impacting specialized therapies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/olartemoure.com\/revision-control-precios-medicamentos\/\" \/>\n<meta property=\"og:site_name\" content=\"OlarteMoure | Intellectual Property\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-18T12:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/olartemoure.com\/wp-content\/uploads\/2026\/05\/drug-price-control.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1601\" \/>\n\t<meta property=\"og:image:height\" content=\"837\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nicole Diaz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nicole Diaz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/revision-control-precios-medicamentos\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/revision-control-precios-medicamentos\\\/\"},\"author\":{\"name\":\"Nicole Diaz\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#\\\/schema\\\/person\\\/39418ad779f2cd1c62156f11faaf2e31\"},\"headline\":\"Colombia Revises Drug Price Controls\",\"datePublished\":\"2026-05-18T12:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/revision-control-precios-medicamentos\\\/\"},\"wordCount\":222,\"image\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/revision-control-precios-medicamentos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/drug-price-control.jpg\",\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/revision-control-precios-medicamentos\\\/\",\"url\":\"https:\\\/\\\/olartemoure.com\\\/revision-control-precios-medicamentos\\\/\",\"name\":\"Colombia Revises Drug Price Controls - OlarteMoure | Intellectual Property\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/revision-control-precios-medicamentos\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/revision-control-precios-medicamentos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/drug-price-control.jpg\",\"datePublished\":\"2026-05-18T12:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#\\\/schema\\\/person\\\/39418ad779f2cd1c62156f11faaf2e31\"},\"description\":\"The update broadens adjustments to 40 entries, a 74 percent increase impacting specialized therapies.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/revision-control-precios-medicamentos\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/olartemoure.com\\\/revision-control-precios-medicamentos\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/revision-control-precios-medicamentos\\\/#primaryimage\",\"url\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/drug-price-control.jpg\",\"contentUrl\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/drug-price-control.jpg\",\"width\":1601,\"height\":837,\"caption\":\"drug price control\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/revision-control-precios-medicamentos\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Colombia Revises Drug Price Controls\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#website\",\"url\":\"https:\\\/\\\/olartemoure.com\\\/\",\"name\":\"OlarteMoure | Intellectual Property\",\"description\":\"Firma especializada en Propiedad Intelectual\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/olartemoure.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#\\\/schema\\\/person\\\/39418ad779f2cd1c62156f11faaf2e31\",\"name\":\"Nicole Diaz\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6e70a134bc45bb3d433d7aa60e3430b15ff974aaed0e63157795bc7a56800ee8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6e70a134bc45bb3d433d7aa60e3430b15ff974aaed0e63157795bc7a56800ee8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6e70a134bc45bb3d433d7aa60e3430b15ff974aaed0e63157795bc7a56800ee8?s=96&d=mm&r=g\",\"caption\":\"Nicole Diaz\"},\"sameAs\":[\"https:\\\/\\\/www.olartemoure.com\"],\"url\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/author\\\/webmaster\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Colombia Revises Drug Price Controls - OlarteMoure | Intellectual Property","description":"The update broadens adjustments to 40 entries, a 74 percent increase impacting specialized therapies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/olartemoure.com\/revision-control-precios-medicamentos\/","og_locale":"en_US","og_type":"article","og_title":"Colombia Revises Drug Price Controls","og_description":"The update broadens adjustments to 40 entries, a 74 percent increase impacting specialized therapies.","og_url":"https:\/\/olartemoure.com\/revision-control-precios-medicamentos\/","og_site_name":"OlarteMoure | Intellectual Property","article_published_time":"2026-05-18T12:00:00+00:00","og_image":[{"width":1601,"height":837,"url":"https:\/\/olartemoure.com\/wp-content\/uploads\/2026\/05\/drug-price-control.jpg","type":"image\/jpeg"}],"author":"Nicole Diaz","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Nicole Diaz","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/olartemoure.com\/revision-control-precios-medicamentos\/#article","isPartOf":{"@id":"https:\/\/olartemoure.com\/revision-control-precios-medicamentos\/"},"author":{"name":"Nicole Diaz","@id":"https:\/\/olartemoure.com\/#\/schema\/person\/39418ad779f2cd1c62156f11faaf2e31"},"headline":"Colombia Revises Drug Price Controls","datePublished":"2026-05-18T12:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/olartemoure.com\/revision-control-precios-medicamentos\/"},"wordCount":222,"image":{"@id":"https:\/\/olartemoure.com\/revision-control-precios-medicamentos\/#primaryimage"},"thumbnailUrl":"https:\/\/olartemoure.com\/wp-content\/uploads\/2026\/05\/drug-price-control.jpg","articleSection":["Newsletter"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/olartemoure.com\/revision-control-precios-medicamentos\/","url":"https:\/\/olartemoure.com\/revision-control-precios-medicamentos\/","name":"Colombia Revises Drug Price Controls - OlarteMoure | Intellectual Property","isPartOf":{"@id":"https:\/\/olartemoure.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/olartemoure.com\/revision-control-precios-medicamentos\/#primaryimage"},"image":{"@id":"https:\/\/olartemoure.com\/revision-control-precios-medicamentos\/#primaryimage"},"thumbnailUrl":"https:\/\/olartemoure.com\/wp-content\/uploads\/2026\/05\/drug-price-control.jpg","datePublished":"2026-05-18T12:00:00+00:00","author":{"@id":"https:\/\/olartemoure.com\/#\/schema\/person\/39418ad779f2cd1c62156f11faaf2e31"},"description":"The update broadens adjustments to 40 entries, a 74 percent increase impacting specialized therapies.","breadcrumb":{"@id":"https:\/\/olartemoure.com\/revision-control-precios-medicamentos\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/olartemoure.com\/revision-control-precios-medicamentos\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/olartemoure.com\/revision-control-precios-medicamentos\/#primaryimage","url":"https:\/\/olartemoure.com\/wp-content\/uploads\/2026\/05\/drug-price-control.jpg","contentUrl":"https:\/\/olartemoure.com\/wp-content\/uploads\/2026\/05\/drug-price-control.jpg","width":1601,"height":837,"caption":"drug price control"},{"@type":"BreadcrumbList","@id":"https:\/\/olartemoure.com\/revision-control-precios-medicamentos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/olartemoure.com\/en\/"},{"@type":"ListItem","position":2,"name":"Colombia Revises Drug Price Controls"}]},{"@type":"WebSite","@id":"https:\/\/olartemoure.com\/#website","url":"https:\/\/olartemoure.com\/","name":"OlarteMoure | Intellectual Property","description":"Firma especializada en Propiedad Intelectual","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/olartemoure.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/olartemoure.com\/#\/schema\/person\/39418ad779f2cd1c62156f11faaf2e31","name":"Nicole Diaz","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/6e70a134bc45bb3d433d7aa60e3430b15ff974aaed0e63157795bc7a56800ee8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/6e70a134bc45bb3d433d7aa60e3430b15ff974aaed0e63157795bc7a56800ee8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6e70a134bc45bb3d433d7aa60e3430b15ff974aaed0e63157795bc7a56800ee8?s=96&d=mm&r=g","caption":"Nicole Diaz"},"sameAs":["https:\/\/www.olartemoure.com"],"url":"https:\/\/olartemoure.com\/en\/author\/webmaster\/"}]}},"_links":{"self":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/posts\/4428289","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/comments?post=4428289"}],"version-history":[{"count":1,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/posts\/4428289\/revisions"}],"predecessor-version":[{"id":4428368,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/posts\/4428289\/revisions\/4428368"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/media\/4428291"}],"wp:attachment":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/media?parent=4428289"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/categories?post=4428289"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/tags?post=4428289"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}